Previous Article | Next Article 
Infection and Immunity, April 1999, p. 1853-1859, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Oligomerization of Anthrax Toxin Protective Antigen and Binding
of Lethal Factor during Endocytic Uptake into Mammalian Cells
Yogendra
Singh,1
Kurt R.
Klimpel,2
Seema
Goel,1
Prabodha K.
Swain,1 and
Stephen H.
Leppla2,*
Centre for Biochemical Technology, Delhi 110007, India,1 and Oral Infection and Immunity
Branch, National Institute of Dental and Craniofacial Research,
National Institutes of Health, Bethesda, Maryland
208922
Received 11 August 1998/Returned for modification 18 September
1998/Accepted 19 January 1999
 |
ABSTRACT |
The protective antigen (PA) protein of anthrax toxin binds to a
cellular receptor and is cleaved by cell surface furin to produce a
63-kDa fragment (PA63). The receptor-bound PA63 oligomerizes to a
heptamer and acts to translocate the catalytic moieties of the toxin,
lethal factor (LF) and edema factor (EF), from endosomes to the
cytosol. In this report, we used nondenaturing gel electrophoresis to
show that each PA63 subunit in the heptamer can bind one LF molecule.
Studies using PA immobilized on a plastic surface showed that monomeric
PA63 is also able to bind LF. The internalization of PA and LF by cells
was studied with radiolabeled and biotinylated proteins.
Uptake was relatively slow, with a half-time of 30 min. The number of
moles of LF internalized was nearly equal to the number of moles
of PA subunit internalized. The essential role of PA
oligomerization in LF translocation was shown with PA protein cleaved
at residues 313-314. The oligomers formed by these proteins during
uptake into cells were not as stable when subjected to heat and
detergent as were those formed by native PA. The results show that the
structure of the toxin proteins and the kinetics of proteolytic
activation, LF binding, and internalization are balanced in a way that
allows each PA63 subunit to internalize an LF molecule. This set of
proteins has evolved to achieve highly efficient internalization and
membrane translocation of the catalytic components, LF and EF.
 |
INTRODUCTION |
Protective antigen (PA), lethal
factor (LF), and edema factor (EF) are three large proteins secreted by
Bacillus anthracis which are collectively known as anthrax
toxin (16, 17, 32). The PA component binds to a specific
cell surface receptor (7) and causes internalization and
translocation of LF and EF across the endosomal membrane to the cytosol
(10, 15). EF and LF contain the catalytic domains of anthrax
toxin. EF has adenylyl cyclase activity (15), and LF is a
zinc-dependent metalloprotease (12) that is known to cleave
at least two targets, mitogen-activated protein kinase kinases 1 and 2 (6, 33). The combination of PA and LF, known as lethal
toxin, causes lysis of mouse macrophages within 120 min (8,
11). The PA protein has structurally distinct domains for
performing the functions of receptor binding and translocation of the
catalytic moieties across endosomal membranes (17, 25).
The mechanism by which individual toxin components interact to cause
toxicity was recently reviewed (17). PA binds to a specific
cell surface receptor (7) and is cleaved at the sequence RKKR167 by cellular proteases including furin (13,
21). The receptor-bound 63-kDa carboxyl-terminal fragment (PA63)
has a site to which LF or EF binds (18). The receptor-bound
PA63 complex with LF or EF is internalized by endocytosis to an acidic
compartment. The transfer of LF or EF to the cytosol appears to occur
through a channel formed by low-pH-induced insertion of PA63 into the
membrane (34). The formation of ion-conductive channels by
PA63 has been demonstrated in both artificial lipid membranes
(5) and CHO cells (19). A soluble,
oligomeric form of PA63 produced in vitro which may correspond to the
membrane channel was demonstrated by sedimentation equilibrium
(16) and gel electrophoresis (16, 30). Electron
microscopy showed that the oligomer formed in vitro is predominantly a
heptamer (20). In a recent study, residues of PA lining the
lumen of the heptameric channel were identified (3). PA
internalized by cells or exposed to low pH on the cell surface produces
oligomers which survive heating in sodium dodecyl sulfate (SDS)
(20).
Injection of lethal toxin produces symptoms in experimental animals
that closely resemble those seen during B. anthracis
infections, and B. anthracis strains lacking only LF
have very low virulence (26). This and other evidence show
that the anthrax lethal toxin is the major virulence factor. The
potency of lethal toxin for animals and cells depends on the amount of
LF delivered to the cytosol. We wished to delineate the interactions of
LF and PA which determine the efficiency of the internalization
process. Here, we report that both the monomeric and the oligomeric
forms of PA63 bind LF in a 1:1 ratio. The potency of anthrax lethal toxin depends upon the amount of LF associated with the PA oligomer. In
addition, we demonstrate that 50% of receptor-bound PA is internalized in 30 min.
 |
MATERIALS AND METHODS |
Reagents and general procedures.
Chemicals and resins were
purchased from Pharmacia. 125I-Bolton-Hunter reagent
(2,000 Ci/mmol) and 125I-streptavidin (20 mCi/mg)
were purchased from Amersham Corp. N-[6-(Biotinamido)hexyl]-3'-(2'-pyridyldithio)
propionamide (biotin-HPDP), maleimide-activated (EZ-Link) horseradish
peroxidase (HRP), and modified avidin-coated plates (NeutrAvidin) were
purchased from Pierce. RAW264.7 cells were obtained from the American
Type Culture Collection. Trypsin and chymotrypsin were purchased from Sigma.
Preparation of PA and LF proteins.
For preparation of PA
proteins, plasmid pYS5 (29) or derivatives carrying mutated
PA genes were transformed into B. anthracis UM23C1-1
and grown in FA medium with 20 µg of neomycin per ml for 16 h at
37°C. PA G735C was constructed by overlap PCR; it retains full
toxicity. PA proteins were purified as described previously
(13). For some experiments, PA and LF were radiolabeled with
125I-Bolton-Hunter reagent.
LF truncated at residue 254 and extended with the sequence GGCGG was
prepared as a fusion to glutathione S-transferase (GST) in
the vector pGEX-KG according to methods previously described for LF
fusion proteins (2). The resulting plasmid pNA86 was transformed into Escherichia coli SG12036 (kindly provided
by Susan Gottesman, National Cancer Institute), which has mutations in
the gal, lon, and sulA genes. Cultures
were grown in super broth to an A600 of 0.8, and
IPTG (isopropyl-
-D-thiogalactopyranoside) was added to a
final concentration of 1 mM. The culture was grown for an additional
4 h, and bacteria were pelleted at 4°C. The protein was purified
on glutathione-Sepharose 4B resin (Pharmacia) and cleaved with
thrombin. The resulting LF1-254-GGCGG protein was
separated from GST by chromatography on a MonoQ column (Pharmacia) with
an NaCl gradient in 10 mM Tricine, pH 8.
Biotinylation of PA.
PA G735C was biotinylated with 17 molar
equivalents of biotin-HPDP (Pierce Chemicals) for 90 min at 23°C in
10 mM HEPES-25 mM NaCl, pH 7.4. Excess reagent was removed by four
cycles of concentration and dilution in an ultrafiltration device
(Centricon-30; Amicon, Inc.).
Purification of PA63 oligomer and PA63 oligomer containing
biotin.
Native PA (600 µg) alone or mixed with biotinylated PA
G735C (100 µg) was cleaved with 1 µg of trypsin per ml for 30 min
at 25°C in 25 mM HEPES-1 mM CaCl2-0.5 mM EDTA, pH
7.4. Protease was inactivated by adding 10 µg of
4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF; Boehringer
Mannheim) per ml. The cleaved PA protein was run on a MonoQ column
(Pharmacia) and eluted with an NaCl gradient in 10 mM BisTrisPropane,
pH 9.0. The fraction containing the PA63 oligomer was pooled, and
protein was assayed with bicinchoninic acid reagent (Pierce).
Coupling of LF1-254-GGCGG to maleimide-activated
HRP.
Purified LF1-254-GGCGG was coupled to a
maleimide-containing HRP. LF1-254-GGCGG (1.0 mg) was
treated with 0.5 mM dithiothreitol (DTT) in 10 mM HEPES, pH 7.4, for 30 min to fully reduce the sulfhydryl residue of the cysteine. DTT was
removed by gel filtration on Sephadex G-25 (PD-10 column; Pharmacia) in 100 mM Na phosphate-5 mM EDTA, pH 7.6. Maleimide-activated HRP (1.6 mg; Pierce Chemicals) was added and incubated for 12 h at 23°C.
Any remaining maleimide residues were inactivated by adding DTT to 1 mM
for 60 min at 23°C. DTT was removed by passing the protein through a
PD-10 column.
Binding of LF to PA in solution.
Gradient Phast gels (4 to
15%; Pharmacia) were soaked in buffer (0.112 M acetic acid, 0.112 M
Tris [pH 6.4],
containing 2 mg of 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonic acid [CHAPS]
per ml) for 2 h, blotted to remove excess liquid, and then allowed
to dry in air until they reached their original weight. Buffer strips
were made from 2% isoelectric focusing agarose type VIII (Sigma)-0.88
M L-alanine-0.25 M Tris (pH 8.8), containing 2 mg of CHAPS
per ml. Both PA and protease-treated PA were incubated with LF in a
sample buffer of 50 mM 2-[N-cyclohexylamino]ethanesulfonic acid (CHES), pH 9.0, containing 2 mg of CHAPS per ml for 30 min at room
temperature. Gels were run for 80 V · h with the Pharmacia Phast
gel program recommended for nondenaturing gels. The gels were stained
in Coomassie brilliant blue R-250, destained, and dried.
LF binding studies using PA immobilized on 96-well plates.
The ability of LF to bind to PA was measured with
LF1-254-GGCGG-HRP and the biotinylated PA G735C
immobilized on 96-well plates coated with a modified avidin
(NeutrAvidin plates; Pierce Chemicals). All additions were made in
100-µl portions, and incubations were at 23°C. Varying
concentrations of biotinylated PA G735C were added to the 96-well
plates and incubated for 2.5 h. Unbound PA was removed by washing
four times with 25 mM Tris (pH 7.6)-50 mM NaCl-0.05% Tween 20-1%
bovine serum albumin (BSA) (buffer A). In some wells, the bound PA was
treated for 25 min with 1 µg of trypsin per ml in 10 mM HEPES, pH
7.4. Trypsin was inactivated by adding 10 µg of soybean trypsin
inhibitor per ml and washing three times with buffer A. LF1-254-GGCGG-HRP was added at 15 µg/ml and incubated
for 90 min. The wells were washed four times with buffer A, and the
amount of bound HRP was determined by adding 1 mg of
2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) in 100 mM
Na citrate, pH 4.5, and recording the A405.
Cell culture and cytotoxicity assays.
RAW264.7 macrophages
were maintained in Dulbecco's modified Eagle's medium (DMEM) with
0.45% glucose, 10% fetal bovine serum, and 2 mM glutamine. LF bound
to PA63 oligomer in various ratios was assayed for toxicity in the
macrophage lysis assay with
3-[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide (MTT) to
determine viability (28).
Binding and uptake of LF and PA by cells.
Binding of LF and
PA to RAW264.7 cells was measured at 4 and 37°C in 12-well plates
with radiolabeled proteins. LF and PA were iodinated with
125I-Bolton-Hunter reagent to specific activities of
1.86 × 106 and 1.6 × 106 dpm/µg,
respectively, as determined by densitometry and subsequent counting of
Coomassie blue-stained gels. Iodination with Bolton-Hunter reagent had
no effect on the biological activity of PA or LF. For binding
experiments at 4°C, cells were placed at 4°C for 15 min. The medium
was replaced with 4°C minimum essential medium containing Earle's
salts without bicarbonate and supplemented with 1% BSA and 25 mM
HEPES, pH 7.4, and containing 125I-PA at 0.1 µg/ml either
alone or with 0.5 µg of 125I-LF per ml. The cells were
incubated for 12 h and washed, and the cell-associated
radioactivity was measured. The protocol for binding and uptake at
37°C was identical, except that DMEM containing 10% serum was used
and uptake was allowed for 2 h.
Cellular internalization of biotinylated PA.
The
internalization of PA was also measured by using biotin-labeled PA
G735C and 125I-streptavidin as described by Pinet et al.
(27). PA G735C was biotinylated, and a portion was cleaved
with trypsin as described above. RAW264.7 cells in 24-well plates were
incubated with 0.5 µg of biotinylated PA G735C per ml in DMEM with
0.45% glucose, 2 mM glutamine, 1% BSA, and 25 mM HEPES (medium A) for
5 h at 4°C. The cells were washed four times with cold medium A
to remove unbound biotinylated PA G735C. Warm medium was added to cause PA internalization for various times. The internalization of PA was
stopped by adding cold medium A containing 0.4 µCi of
125I-streptavidin per ml, and cells were incubated for
1 h at 4°C. The cells were washed with cold medium A, and
radioactivity was determined. Nonspecific binding was determined by
incubating the cells for 15 min in 50 mM glutathione-75 mM
NaCl-10 mM EDTA, pH 7.2, in DMEM containing 1% BSA to remove
surface-bound biotin prior to addition of
125I-streptavidin.
 |
RESULTS AND DISCUSSION |
Proteolytic cleavage of PA at the furin site, RKKR167,
either in solution (16) or on the cell surface
(13), leads to the exposure of a high-affinity binding site
for LF and EF on the 63-kDa carboxyl-terminal fragment (PA63). Cleavage
of PA also results in the formation of a defined oligomeric form of
PA63 (16), which has been visualized by electron
microscopy as a heptameric ring (20). We and
others believe that this heptameric PA63 is a soluble form of the
membrane-inserted channel through which LF and EF translocate to the
cytosol (17, 20). Little is known about the stoichiometry or
affinity of LF and EF binding to PA63. We sought to characterize the
oligomerization of PA63, the binding of LF, and the role of these
events in the internalization process that leads to toxicity. All the
work reported here used LF rather than EF, because LF is more easily
purified. However, previous work showed that the interactions of LF and
EF with PA are qualitatively identical (16), so it follows
that results described here for LF are likely to apply equally well to EF.
Interaction of LF with PA63 in solution.
The interaction of
PA63 and LF in solution was studied by gel electrophoresis under
nondenaturing conditions. Previous work showed that the purified PA63
oligomer was most soluble at elevated pH in CHAPS detergent (16,
30). Because the heptameric PA63 is very large (calculated
molecular weight [MW] = 440,000), gels with low polyacrylamide
concentrations were used to obtain adequate electrophoretic mobility.
An effective electrophoresis system was developed by modifying
commercial gels prepared on plastic backing (Phast gels; 4 to 15%
polyacrylamide gradient). These gels were soaked in a pH 8.8 buffer
containing CHAPS. Agarose buffer strips containing an alanine solution
that produces a stacking effect were prepared. In this electrophoresis
system, native PA and LF have high mobility (Fig.
1A, lanes 1 and 3). PA was cleaved at the
RKKR167 site with low concentrations of trypsin and then
incubated at pH 9.0 with LF to allow complex formation. The
trypsin-cleaved PA in the absence of LF formed a diffuse, slowly
migrating band, suggesting that it had oligomerized either prior to or
during electrophoresis (Fig. 1A, lane 2). Addition of LF caused this diffuse band to sharpen and migrate even more slowly (Fig. 1A, lanes 4 to 6), indicating that LF was binding to the PA63 complex. The change
in mobility of LF due to binding to PA63 will be referred to here as a
gel shift.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 1.
Binding of LF to PA in solution. Increasing amounts of
LF were incubated with PA that had been nicked with trypsin for 30 min
at room temperature. Samples were separated on 4 to 15% gradient gels
(Phast) and stained with Coomassie blue. (A) Lane 1, 270 ng of native
(unnicked) PA; lane 2, 270 ng of PA nicked with trypsin; lane 3, 270 ng
of LF; lanes 4 to 6, 270 ng of trypsin-nicked PA and 135, 270, and 540 ng of LF, respectively. (B) Lanes 1 to 6, 270 ng of trypsin-nicked PA
and increasing amounts of LF (243, 270, 297, 337, 378, and 405 ng,
respectively). The mass ratio of LF to PA is indicated above each lane.
The results are representative of the three analyses performed.
|
|
The stoichiometry of binding was estimated by adding increasing amounts
of LF to a fixed amount of PA63. No free LF was observed
when the
amount of LF was one-half of or equal to the amount of
PA (Fig.
1A,
lanes 4 and 5), indicating that all the LF was associated
with the
slowly migrating PA63 band. When the amount of LF was
increased to
twice that of PA, half of the LF migrated as free
LF (Fig.
1A, lane 6).
This result suggests that the PA63 heptamer
is able to bind
approximately an equal weight of LF. The absence
of any free LF when
the mass ratio is 1:1 indicates that the affinity
of PA63 for LF is
very
high.
A more precise measurement of the capacity of PA63 to bind LF was made
by adding amounts of LF that were more nearly equal
to the amount of
PA63 (Fig.
1B). In this case, small amounts of
free LF first became
visible in lane 2, which contained 270 ng
of LF and 270 ng of
trypsin-nicked PA, for an LF/PA mass ratio
of 1.0, as labeled in the
figure. Because the MWs of LF and full-size
PA are 90,200 and 82,700, respectively, this corresponds to a
molar ratio of 0.9. As the amount
of LF was increased further,
the band of free LF increased
proportionately, indicating that
the slower-migrating PA63 oligomer was
saturated with LF. These
data suggest that the PA63 heptamer binds six
to seven LF molecules.
Symmetry considerations suggest that the actual
number is
seven.
The fact that the oligomeric PA63 can bind an equal amount of LF shows
that multiple molecules of LF are binding. Indeed,
the data of Fig.
1
imply that a heptameric PA63 binds approximately
seven LF molecules. It
therefore appeared probable that intermediate
species containing fewer
LF molecules might exist at low relative
concentrations of LF.
Alternatively, if LF binding were highly
cooperative, then intermediate
species might not be detectable.
To analyze PA63 complexes containing
less than stoichiometric
amounts of LF, we used purified PA63 because
it produces sharper
bands in the gel shift system. PA63 was obtained by
chromatography
of trypsin-nicked PA as described in Materials and
Methods. Gel
electrophoresis of mixtures containing limiting amounts of
LF
with purified PA63 is shown in Fig.
2.
As in Fig.
1, saturating
amounts of LF produce a band of free LF near
the bottom of the
gel (Fig.
2, lane "2.0"). Incubation of the PA63
oligomer with
limiting amounts of LF caused formation of PA63-LF
complexes with
varying numbers of LF molecules. The intensities of the
bands
did not change in direct proportion to their mobilities, implying
that individual LF molecules may not bind independently. The prominent
band observed in all samples with LF/PA ratios of 0.4 to 2.0 (Fig.
2)
may be a complex having equal numbers of PA63 and LF molecules,
presumably seven of each. These lanes also contain two faint bands
above the putative 7:7 complex. These bands may represent complexes
containing denatured proteins which can interact but not pack
into a
compact structure. A more "open" structure of the same
MW would
have lower mobility. The possibility that these bands
are a complex
containing five to six LF molecules, and therefore
are less tightly
packed, is also possible, although one would
expect such a complex to
disappear at higher LF concentrations
like those in the right-hand
lanes.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 2.
Determination of multimeric forms of PA-LF complex.
Purified PA63 (468 ng) was incubated with various amounts of LF for 30 min at room temperature. Samples were separated on 4 to 15% Phast
gradient gels. Lanes 1 to 8, increasing amounts of LF (0, 47, 94, 187, 374, 515, 562, and 936 ng, respectively). The mass ratio of LF to PA is
indicated above each lane. The results are representative of the three
analyses performed.
|
|
The data from the nondenaturing gels suggest that the PA63 oligomer is
able to bind variable numbers of LF molecules up to
a maximum of seven.
However, the data do not indicate which of
these PA-LF complexes is
biologically active. It is possible that
PA-LF complexes with any
number of LF molecules will be active
and that the potency may increase
with increasing amounts of LF.
The potency of PA63 oligomer associated
with various amounts of
LF was resolved in an another experiment in
which the PA63 oligomer
complexed with various amounts of LF was added
to the RAW264.7
cells and incubated for 2.5 h at 37°C. The
potency of PA63 oligomer
in lysing RAW264.7 cells increased with
increasing amounts of
associated LF (Fig.
3). These results further confirmed the
observation
for Fig.
2 that PA oligomer can bind one or more LF
molecules
and also showed that the potency of the lethal toxin depends
on
the amount of LF bound to PA oligomer.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 3.
Potency of PA oligomer bound to various ratios of LF.
Aliquots of purified PA63 at 10 µg/ml were incubated with various
amounts of LF for 30 min at room temperature. The resulting PA63-LF
complexes were serially diluted and added to the RAW264.7 cells and
incubated for 2.5 h at 37°C in a CO2 incubator. The
labels on the lines refer to the molar ratios of PA63 to LF during the
preincubation. For the curve "PA-LF," LF was added at 0.5 µg/ml
to all wells and the indicated concentration of PA63 was added
separately. Cell lysis was determined by MTT assay. The results are
representative of the three analyses performed.
|
|
Role of PA63 oligomerization in binding of LF.
For LF to be
delivered to the cytosol of target cells, it must bind to the
receptor-bound, proteolytically activated form of PA, PA63. It is well
established that proteolytic activation of PA is a prerequisite for
membrane insertion, oligomerization, and LF binding. However, it is not
known whether each of these three events can occur independently or
whether these events must occur in a particular order. To begin
answering these questions, we determined whether monomeric PA63 is able
to bind LF. Simple measurements in solution cannot answer this question
because trypsin- or furin-nicked PA oligomerizes rapidly. Therefore, we
immobilized PA on a plastic surface so as to prevent its
oligomerization after cleavage. This approach was aided by the
availability of PA G735C, a fully toxic mutant (unpublished results).
Because native PA contains no Cys residues, the single Cys residue
added at the C terminus provides a unique sulfhydryl group through
which PA can be immobilized in a known orientation. The carboxyl
terminus of PA is involved in receptor binding (31) and is
at the opposite end of the protein from the LF binding site. Therefore,
modifications at the COOH terminus are not expected to have any effect
on trypsin cleavage or LF binding. The single cysteine was reacted with
a sulfhydryl-specific biotinylating reagent, and varying amounts of the
resulting biotinylated PA were then bound to commercial plastic 96-well
plates coated with a modified avidin and blocked to prevent nonspecific
binding. The immobilized, biotin-PA G735C was treated with trypsin, and
the ability to bind LF was measured with a chemical conjugate of the
PA-binding region of LF with HRP (LF1-254GGCGG-HRP). The
binding of the LF conjugate increased approximately linearly with the
amount of PA used as a coating on the 96-well plates (Fig.
4, monomer), saturating at about 200 to
300 ng/well. Competition with native LF showed that >90% of the
LF1-254GGCGG-HRP binding was specific. Binding in the
absence of trypsin treatment was less than 20% of the specific,
trypsin-dependent binding (data not shown). Although it might be argued
that some of the immobilized PA63 could assemble into oligomers, we
consider it unlikely that a significant fraction of the tethered PA63
molecules could contact each other in the precise orientation needed to
form oligomers. Furthermore, oligomerization would be highly dependent
on the concentration of surface-bound PA63, so that there would be an
exponential increase in LF binding versus PA concentration, and this is
not observed. The ability of the LF conjugate to bind to the
immobilized PA protein strongly suggests that monomeric PA has high
affinity for LF.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 4.
Binding of LF1-254-GGCGG-HRP to PA monomer
or oligomer on enzyme-linked immunosorbent assay plates. PA
G735C-biotin (0.01 to 1 µg/well; monomer) or PA63 made from a 6:1
mixture of PA and PA G735C-biotin (0.01 to 0.1 µg/well; oligomer) was
applied as a coating to avidin-coated plates for 3 h at 23°C.
Unbound PA was removed by washing four times with 25 mM Tris, pH 7.6, containing 1% BSA, 0.05% Tween 20, and 50 mM NaCl (buffer A). The PA
G735C-biotin attached to the immobilized avidin (monomer) was treated
with trypsin (100 µl, 1 µg/ml) in 10 mM HEPES, pH 7.4, for 25 min
at 23°C. Trypsin was inactivated by adding soybean trypsin inhibitor
(100 µl, 10 µg/ml) and again washed three times with buffer A. LF1-254-GGCGG-HRP (100 µl, 15 µg/ml) was added to all
wells and incubated for 90 min at 23°C. The excess
LF1-254-GGCGG-HRP was removed by washing the wells four
times with buffer A. The color was developed with ABTS, and
A405 was measured in a microplate reader.
A405 values were corrected for the small
activity (<10% of total) in controls containing excess native LF to
compete with LF1-254-GGCGG-HRP. Parallel assays of known
amounts of soluble HRP were used to construct a standard curve by which
A405 values were converted to nanograms of LF.
The experiment was performed three times with results similar to those
shown.
|
|
To compare the amounts of LF that bind to PA monomer and heptamer, a
similar experiment was performed with PA63 oligomer formed
by mixing
native PA and biotinylated PA G735C at a 6:1 ratio and
purifying the
oligomer after trypsin cleavage as described in
Materials and Methods.
In this case, each avidin site could bind
one heptamer, so that there
may be as much as sevenfold more PA63
bound than in the case where
intact biotin-PA is added and then
trypsin treated. Consistent with
this view, the oligomer bound
much more LF conjugate than did monomer
(Fig.
4, oligomer). These
results show that both monomeric and
oligomeric forms of PA63
can bind LF and confirm the earlier results
that the oligomeric
PA63 can bind multiple LF
molecules.
Stoichiometry of PA and LF binding to cells.
The results
described above show that LF binds very tightly to PA63 and that
oligomerization of PA63 is not required prior to LF binding. To
determine whether similar events occur on the surface of cells, we
measured the stoichiometry of LF and PA binding to the mouse macrophage
cell line RAW264.7. Cells were incubated with 0.1 µg of
125I-PA per ml alone or in combination with 0.5 µg of
125I-LF per ml for 12 h at 4°C or 2 h at
37°C, and cell-associated radioactivity was measured (Table
1). The amounts of LF bound to the cells
were estimated by subtracting the radioactivity in wells containing PA
alone. At 4°C, PA binds, becomes nicked by cell surface furin
(13, 21), and then binds LF. Prior studies show that a 12-h
incubation at 4°C leads to nearly complete nicking of receptor-bound
PA (30). If the binding interactions identified by the in
vitro studies described above accurately reflect events on cells, it
would be expected that LF would bind in amounts equal to that of PA.
Equimolar binding of LF and PA was indeed observed (Table 1, 4°C
data).
A similar analysis was done at 37°C, under conditions where endocytic
uptake of both PA and LF occurs. The amounts of PA and
LF associated
with the cells after the 2-h incubation were fourfold
greater than
those at 4°C (Table
1), suggesting that an amount
of receptor equal
to that on the cell surface is internalized
and replaced every 30 min.
The molar amounts of LF bound and internalized
were nearly equal to
that of PA. These data suggest that nearly
every molecule of PA binds
and delivers a molecule of LF into
endosomes. The rate of
internalization was also measured by a
more direct assay to be
described
below.
Role of PA63 oligomerization in LF translocation.
Although
proteolytic cleavage of PA is essential to toxicity
(29) and cleavage leads to oligomerization of
PA63 (16, 20), it has not been proven that oligomerization
is required for LF translocation and toxicity. To study the role of
oligomerization in productive internalization, we performed experiments
using chymotrypsin-nicked, radioiodinated PA. Chymotrypsin-nicked PA can bind to the cellular receptor, be activated by furin, and bind LF, but it is biologically inactive (16, 24).
Although the gel shift assay showed that chymotrypsin-nicked PA could
form oligomers in vitro (30), assays for oligomer formation
on cells were not reported. The data in Fig.
5 show that chymotrypsin-nicked PA
incubated with cells at 37°C did not produce SDS- and heat-resistant oligomers. Oligomer was present only in those cells incubated with
native or trypsin-nicked PA. The inability of chymotrypsin-nicked PA to
form stable oligomers and its lack of toxicity when combined with LF
suggest that the stable oligomer formation seen in cells is an
essential step in delivery of LF to the cytosol.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 5.
Oligomerization of PA on cells. RAW264.7 cells were
cultured in 12-well tissue culture plates. 125I-PA was
cleaved with trypsin, chymotrypsin, or both and then incubated with
cells for 3 h at 37°C in DMEM containing 10% serum and 2 mM
glutamine. Cells were washed four times with the same medium,
solubilized in SDS sample buffer, heated for 5 min at 95°C, and
separated on 10% polyacrylamide gels in SDS. Volumes containing 900 cpm were loaded in each lane, and the gel was exposed to X-ray film for
6 days. Lane 1, PA (no cell incubation); lane 2, chymotrypsin-nicked
PA; lane 3, trypsin- and chymotrypsin-nicked PA; lane 4, trypsin-nicked
PA; lane 5, PA; lane 6, PA partially nicked with chymotrypsin (no cell
incubation; "P" denotes partial digest). The results shown are
representative of the two analyses performed. Numbers at right show
molecular mass in kilodaltons.
|
|
PA receptor internalization rate.
The rate and extent of
internalization of the PA-LF complex are determined largely by the
properties of the PA receptor. Cell surface receptors for several
bacterial toxins have been identified and characterized (14,
23), but that for PA remains unidentified. The PA receptor
appears to be a protein which is present at 2,000 to 50,000 copies per
cell (7, 9, 16). Reported dissociation constants average
10
9 M. Because of the unique requirement that
receptor-bound PA be cleaved before it can bind LF, the rate of PA
internalization relative to proteolytic activation is a critical
determinant of the efficiency of LF delivery to the cytosol. That is,
if internalization of PA were rapid relative to proteolytic cleavage,
then most PA molecules would be endocytosed before capturing an LF molecule.
To investigate the rate of internalization of the PA receptor, we
adopted a sensitive assay utilizing biotinylated PA G735C
(
27). Because the trafficking of some receptors is
influenced
by the properties of the ligand, it was also of interest to
determine
whether uncleaved PA and PA63 are internalized and trafficked
differently. PA G735C was labeled with biotin-HPDP. Although the
Cys
substitution in this mutant is in the region implicated in
receptor
binding (
31), the full toxicity of this mutant PA shows
that
receptor binding is unaffected. A portion of the biotin-labeled
PA
G735C was nicked with trypsin, and both proteins were incubated
with
cells.
125I-streptavidin was used to measure the amount of
biotinylated
PA G735C remaining on the cell surface after various
periods of
internalization. It was found that approximately half the PA
entered
cells in 30 to 40 min (Fig.
6).
Trypsin nicking had no effect
on the rate of internalization,
suggesting that the receptor does
not distinguish between various forms
of PA. The rate of internalization
found in this assay correlates well
with that estimated from the
data of Table
1. This rate of
internalization (3% per min) is
very slow compared to that for
receptors for many protein ligands
(25% per min) but is similar to the
rate at which diphtheria toxin
is internalized (
1).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 6.
Internalization of PA. RAW264.7 cells in 24-well tissue
culture plates were incubated for 5 h at 4°C in medium A (see
Materials and Methods) containing 0.5 µg of biotinylated PA G735C per
ml, either intact or trypsin nicked. The cells were washed and then
incubated at 37°C for varying periods. Internalization of PA was
stopped by adding cold medium containing 125I-streptavidin.
Cells were washed to remove unbound 125I-streptavidin, and
radioactivity was measured. Nonspecific binding was determined by first
stripping surface biotin by incubation in glutathione prior to addition
of 125I-streptavidin. The experiment was repeated three
times with similar results.
|
|
Overview of toxin internalization.
The data presented above
provide a basis for refining the description of the interaction of PA
and LF with cells. As described above, the process of toxin action
begins with PA binding to its receptor and being nicked by furin or
another protease at Arg167. Release of the amino-terminal fragment
removes steric hindrance or allows a conformational change that creates
a high-affinity site for LF or EF. Nicking of PA appears to be quite
slow, with a half-time of at least 30 min at 37°C (30).
The low rate of nicking is not surprising if furin is the responsible
enzyme, because only small amounts of furin are found on the cell
surface compared to the amounts in the trans-Golgi region
(22). It was previously assumed that PA internalization was
relatively rapid and that many molecules of PA would therefore be
endocytosed without being nicked. The new data presented here include
evidence that PA is actually internalized quite slowly. The recognition
that internalization, like nicking, is quite slow makes it evident that
PA remains on the cell surface long enough to become fully nicked. This
interpretation is consistent with, and indeed dictated by, the data in
Table 1 showing that nearly equal amounts of PA and LF are internalized
at 37°C. This can occur only if every PA molecule becomes nicked and
then captures and internalizes an LF molecule.
The next step in toxin action is endocytosis of the PA63-LF complex.
The data do not directly show whether the endocytosed
LF-containing
species is a monomeric or an oligomeric PA63. The
demonstration that
monomeric PA63 can bind LF shows that oligomerization
does not
necessarily precede endocytosis. Perhaps the species
endocytosed is a
mixture of monomeric and oligomeric PA63-LF species.
In the endosome,
acidification leads to membrane insertion of
PA63 and LF translocation
to the cytosol (
10,
16). An unresolved
question that our
data do not address is whether membrane insertion
and oligomerization
must occur in a particular sequence. It can
be noted that
oligomerization does not appear to be a rate-limiting
step, because
dose-response curves do not show the high cooperativity
characteristic
of many multimeric
systems.
Little is understood about the translocation of LF across the endosomal
membrane. Two types of mechanisms can be distinguished.
In one of
these, insertion of the PA63 oligomer into the membrane
would be the
driving force which simultaneously inserts a molecule
of LF into
the membrane. This mechanism implies that the PA63
oligomer might
deliver only a single LF molecule to the cytosol.
The second type of
mechanism would view a preformed PA63 channel
as being competent to
translocate multiple LF molecules. Studies
with artificial lipid
membranes containing PA63 show that translocation
of organic cations is
voltage dependent and that larger cations
can be forced through by
increasing the voltage (
4). If LF
behaves similarly to these
organic cations and multiple molecules
can be translocated, then a
mechanism must exist to transfer LF
from a site at which it is bound
with very high affinity on each
PA63 molecule to a site from which it
can be forced into the channel
lumen to initiate translocation. Direct
measurements of the translocation
efficiency have not been made, so it
is not known whether the
amount of LF translocated to the cytosol is
more consistent with
the first or the second of these
mechanisms.
The anthrax toxin proteins constitute a unique membrane translocation
system which is quite accessible to experimental study.
The proteins
are easily expressed and purified, and translocation
can be
measured in simple cytotoxicity assays. The PA63 channel
appears
able to translocate a number of different polypeptides
(
2). For these reasons, the anthrax toxin proteins provide
an attractive model system of membrane transport, while also providing
a basis for the development of reagents for cell biology and
therapeutics.
 |
ACKNOWLEDGMENTS |
We thank J. K. Batra and Valery M. Gordon for helpful
discussions, Maria Sandkvist and Valery M. Gordon for assistance with the manuscript, Naveen Arora for constructing the plasmid
encoding GST-LF1-254-GGCGG, and Jerry M. Keith
and S. K. Brahmachari for making this work possible.
Y.S. was partially supported by the Rockefeller Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Oral Infection
and Immunity Branch, National Institute of Dental and Craniofacial
Research, Bldg. 30, Rm. 309, NIH, Bethesda, MD 20892. Phone: (301)
594-2865. Fax: (301) 402-0396. E-mail: Leppla{at}nih.gov.
Editor:
J. T. Barbieri
 |
REFERENCES |
| 1.
|
Almond, B. D., and L. Eidels.
1994.
The cytoplasmic domain of the diphtheria toxin receptor (HB-EGF precursor) is not required for receptor-mediated endocytosis.
J. Biol. Chem.
269:26635-26641[Abstract/Free Full Text].
|
| 2.
|
Arora, N., and S. H. Leppla.
1994.
Fusions of anthrax toxin lethal factor with Shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells.
Infect. Immun.
62:4955-4961[Abstract/Free Full Text].
|
| 3.
|
Benson, E. L.,
P. D. Huynh,
A. Finkelstein, and R. J. Collier.
1998.
Identification of residues lining the anthrax protective antigen channel.
Biochemistry
37:3941-3948[Medline].
|
| 4.
|
Blaustein, R. O., and A. Finkelstein.
1990.
Voltage-dependent block of anthrax toxin channels in planar phospholipid bilayer membranes by symmetric tetraalkylammonium ions. Effects on macroscopic conductance.
J. Gen. Physiol.
96:905-919[Abstract/Free Full Text].
|
| 5.
|
Blaustein, R. O.,
T. M. Koehler,
R. J. Collier, and A. Finkelstein.
1989.
Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers.
Proc. Natl. Acad. Sci. USA
86:2209-2213[Abstract/Free Full Text].
|
| 6.
|
Duesbery, N. S.,
C. P. Webb,
S. H. Leppla,
V. M. Gordon,
K. R. Klimpel,
T. D. Copeland,
N. G. Ahn,
M. K. Oskarsson,
K. Fukasawa,
K. D. Paull, and G. F. Vande Woude.
1998.
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
Science
280:734-737[Abstract/Free Full Text].
|
| 7.
|
Escuyer, V., and R. J. Collier.
1991.
Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells.
Infect. Immun.
59:3381-3386[Abstract/Free Full Text].
|
| 8.
|
Friedlander, A. M.
1986.
Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.
J. Biol. Chem.
261:7123-7126[Abstract/Free Full Text].
|
| 9.
|
Friedlander, A. M., and A. Raziuddin.
1992.
Anthrax protective antigen receptor: identification of a protective antigen binding protein by chemical cross-linking, p. 365-366.
In
B. Withholdt (ed.), Bacterial protein toxins. Gustav Fischer, New York, N.Y.
|
| 10.
|
Gordon, V. M.,
S. H. Leppla, and E. L. Hewlett.
1988.
Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin.
Infect. Immun.
56:1066-1069[Abstract/Free Full Text].
|
| 11.
|
Hanna, P. C.,
D. Acosta, and R. J. Collier.
1993.
On the role of macrophages in anthrax.
Proc. Natl. Acad. Sci. USA
90:10198-10201[Abstract/Free Full Text].
|
| 12.
|
Klimpel, K. R.,
N. Arora, and S. H. Leppla.
1994.
Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity.
Mol. Microbiol.
13:1093-1100[Medline].
|
| 13.
|
Klimpel, K. R.,
S. S. Molloy,
G. Thomas, and S. H. Leppla.
1992.
Anthrax toxin protective antigen is activated by a cell-surface protease with the sequence specificity and catalytic properties of furin.
Proc. Natl. Acad. Sci. USA
89:10277-10281[Abstract/Free Full Text].
|
| 14.
|
Kounnas, M. Z.,
R. E. Morris,
M. R. Thompson,
D. J. FitzGerald,
D. K. Strickland, and C. B. Saelinger.
1992.
The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A.
J. Biol. Chem.
267:12420-12423[Abstract/Free Full Text].
|
| 15.
|
Leppla, S. H.
1982.
Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.
Proc. Natl. Acad. Sci. USA
79:3162-3166[Abstract/Free Full Text].
|
| 16.
|
Leppla, S. H.
1991.
The anthrax toxin complex, p. 277-302.
In
J. E. Alouf, and J. H. Freer (ed.), Sourcebook of bacterial protein toxins. Academic Press, London, United Kingdom.
|
| 17.
|
Leppla, S. H.
1995.
Anthrax toxins.
Handb. Nat. Toxins
8:543-572.
|
| 18.
|
Leppla, S. H.,
A. M. Friedlander, and E. Cora.
1988.
Proteolytic activation of anthrax toxin bound to cellular receptors, p. 111-112.
In
F. Fehrenbach, J. E. Alouf, P. Falmagne, W. Goebel, J. Jeljaszewicz, D. Jurgen, and R. Rappuoli (ed.), Bacterial protein toxins. Gustav Fischer, New York, N.Y.
|
| 19.
|
Milne, J. C., and R. J. Collier.
1993.
pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen.
Mol. Microbiol.
10:647-653[Medline].
|
| 20.
|
Milne, J. C.,
D. Furlong,
P. C. Hanna,
J. S. Wall, and R. J. Collier.
1994.
Anthrax protective antigen forms oligomers during intoxication of mammalian cells.
J. Biol. Chem.
269:20607-20612[Abstract/Free Full Text].
|
| 21.
|
Molloy, S. S.,
P. A. Bresnahan,
S. H. Leppla,
K. R. Klimpel, and G. Thomas.
1992.
Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen.
J. Biol. Chem.
267:16396-16402[Abstract/Free Full Text].
|
| 22.
|
Molloy, S. S.,
L. Thomas,
J. K. VanSlyke,
P. E. Stenberg, and G. Thomas.
1994.
Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface.
EMBO J.
13:18-33[Medline].
|
| 23.
|
Naglich, J. G.,
J. E. Metherall,
D. W. Russell, and L. Eidels.
1992.
Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor.
Cell
69:1051-1061[Medline].
|
| 24.
|
Novak, J. M.,
M. P. Stein,
S. F. Little,
S. H. Leppla, and A. M. Friedlander.
1992.
Functional characterization of protease-treated Bacillus anthracis protective antigen.
J. Biol. Chem.
267:17186-17193[Abstract/Free Full Text].
|
| 25.
|
Petosa, C.,
R. J. Collier,
K. R. Klimpel,
S. H. Leppla, and R. C. Liddington.
1997.
Crystal structure of the anthrax toxin protective antigen.
Nature
385:833-838[Medline].
|
| 26.
|
Pezard, C.,
P. Berche, and M. Mock.
1991.
Contribution of individual toxin components to virulence of Bacillus anthracis.
Infect. Immun.
59:3472-3477[Abstract/Free Full Text].
|
| 27.
|
Pinet, V.,
M. Vergelli,
R. Martin,
O. Bakke, and E. O. Long.
1995.
Antigen presentation mediated by recycling of surface HLA-DR molecules.
Nature
375:603-606[Medline].
|
| 28.
|
Quinn, C. P.,
Y. Singh,
K. R. Klimpel, and S. H. Leppla.
1991.
Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis.
J. Biol. Chem.
266:20124-20130[Abstract/Free Full Text].
|
| 29.
|
Singh, Y.,
V. K. Chaudhary, and S. H. Leppla.
1989.
A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo.
J. Biol. Chem.
264:19103-19107[Abstract/Free Full Text].
|
| 30.
|
Singh, Y.,
K. R. Klimpel,
N. Arora,
M. Sharma, and S. H. Leppla.
1994.
The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor.
J. Biol. Chem.
269:29039-29046[Abstract/Free Full Text].
|
| 31.
|
Singh, Y.,
K. R. Klimpel,
C. P. Quinn,
V. K. Chaudhary, and S. H. Leppla.
1991.
The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity.
J. Biol. Chem.
266:15493-15497[Abstract/Free Full Text].
|
| 32.
|
Smith, H., and J. L. Stanley.
1962.
Purification of the third factor of anthrax toxin.
J. Gen. Microbiol.
29:517-521.
|
| 33.
|
Vitale, G.,
R. Pellizzari,
C. Recchi,
G. Napolitani,
M. Mock, and C. Montecucco.
1998.
Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.
Biochem. Biophys. Res. Commun.
248:706-711[Medline].
|
| 34.
|
Wesche, J.,
J. L. Elliott,
P. O. Falnes,
S. Olsnes, and R. J. Collier.
1998.
Characterization of membrane translocation by anthrax protective antigen.
Biochemistry
37:15737-15746[Medline].
|
Infection and Immunity, April 1999, p. 1853-1859, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sela-Abramovich, S., Chitlaru, T., Gat, O., Grosfeld, H., Cohen, O., Shafferman, A.
(2009). Novel and Unique Diagnostic Biomarkers for Bacillus anthracis Infection. Appl. Environ. Microbiol.
75: 6157-6167
[Abstract]
[Full Text]
-
Nguyen, M. L., Crowe, S. R., Kurella, S., Teryzan, S., Cao, B., Ballard, J. D., James, J. A., Farris, A. D.
(2009). Sequential B-Cell Epitopes of Bacillus anthracis Lethal Factor Bind Lethal Toxin-Neutralizing Antibodies. Infect. Immun.
77: 162-169
[Abstract]
[Full Text]
-
Chitlaru, T., Gat, O., Grosfeld, H., Inbar, I., Gozlan, Y., Shafferman, A.
(2007). Identification of In Vivo-Expressed Immunogenic Proteins by Serological Proteome Analysis of the Bacillus anthracis Secretome. Infect. Immun.
75: 2841-2852
[Abstract]
[Full Text]
-
Mabry, R., Brasky, K., Geiger, R., Carrion, R. Jr., Hubbard, G. B., Leppla, S., Patterson, J. L., Georgiou, G., Iverson, B. L.
(2006). Detection of Anthrax Toxin in the Serum of Animals Infected with Bacillus anthracis by Using Engineered Immunoassays. CVI
13: 671-677
[Abstract]
[Full Text]
-
Rono, B., Romer, J., Liu, S., Bugge, T. H., Leppla, S. H., Kristjansen, P. E.G.
(2006). Antitumor efficacy of a urokinase activation-dependent anthrax toxin. Molecular Cancer Therapeutics
5: 89-96
[Abstract]
[Full Text]
-
Zomber, G., Reuveny, S., Garti, N., Shafferman, A., Elhanany, E.
(2005). Effects of Spontaneous Deamidation on the Cytotoxic Activity of the Bacillus anthracis Protective Antigen. J. Biol. Chem.
280: 39897-39906
[Abstract]
[Full Text]
-
Halverson, K. M., Panchal, R. G., Nguyen, T. L., Gussio, R., Little, S. F., Misakian, M., Bavari, S., Kasianowicz, J. J.
(2005). Anthrax Biosensor, Protective Antigen Ion Channel Asymmetric Blockade. J. Biol. Chem.
280: 34056-34062
[Abstract]
[Full Text]
-
Panchal, R. G., Halverson, K. M., Ribot, W., Lane, D., Kenny, T., Abshire, T. G., Ezzell, J. W., Hoover, T. A., Powell, B., Little, S., Kasianowicz, J. J., Bavari, S.
(2005). Purified Bacillus anthracis Lethal Toxin Complex Formed in Vitro and during Infection Exhibits Functional and Biological Activity. J. Biol. Chem.
280: 10834-10839
[Abstract]
[Full Text]
-
Mohamed, N., Clagett, M., Li, J., Jones, S., Pincus, S., D'Alia, G., Nardone, L., Babin, M., Spitalny, G., Casey, L.
(2005). A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge. Infect. Immun.
73: 795-802
[Abstract]
[Full Text]
-
Barth, H., Aktories, K., Popoff, M. R., Stiles, B. G.
(2004). Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins. Microbiol. Mol. Biol. Rev.
68: 373-402
[Abstract]
[Full Text]
-
Sarac, M. S., Peinado, J. R., Leppla, S. H., Lindberg, I.
(2004). Protection against Anthrax Toxemia by Hexa-D-Arginine In Vitro and In Vivo. Infect. Immun.
72: 602-605
[Abstract]
[Full Text]
-
Webster, J. I., Tonelli, L. H., Moayeri, M., Simons, S. S. Jr., Leppla, S. H., Sternberg, E. M.
(2003). Anthrax lethal factor represses glucocorticoid and progesterone receptor activity. Proc. Natl. Acad. Sci. USA
100: 5706-5711
[Abstract]
[Full Text]
-
Liu, S., Leppla, S. H.
(2003). Cell Surface Tumor Endothelium Marker 8 Cytoplasmic Tail-independent Anthrax Toxin Binding, Proteolytic Processing, Oligomer Formation, and Internalization. J. Biol. Chem.
278: 5227-5234
[Abstract]
[Full Text]
-
Mogridge, J., Cunningham, K., Lacy, D. B., Mourez, M., Collier, R. J.
(2002). The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Proc. Natl. Acad. Sci. USA
99: 7045-7048
[Abstract]
[Full Text]
-
Kumar, P., Ahuja, N., Bhatnagar, R.
(2001). Purification of Anthrax Edema Factor from Escherichia coli and Identification of Residues Required for Binding to Anthrax Protective Antigen. Infect. Immun.
69: 6532-6536
[Abstract]
[Full Text]
-
Blocker, D., Behlke, J., Aktories, K., Barth, H.
(2001). Cellular Uptake of the Clostridium perfringens Binary Iota-Toxin. Infect. Immun.
69: 2980-2987
[Abstract]
[Full Text]
-
Marvaud, J.-C., Smith, T., Hale, M. L., Popoff, M. R., Smith, L. A., Stiles, B. G.
(2001). Clostridium perfringens Iota-Toxin: Mapping of Receptor Binding and Ia Docking Domains on Ib. Infect. Immun.
69: 2435-2441
[Abstract]
[Full Text]
-
Cortes-Bratti, X., Chaves-Olarte, E., Lagergard, T., Thelestam, M.
(2000). Cellular Internalization of Cytolethal Distending Toxin from Haemophilus ducreyi. Infect. Immun.
68: 6903-6911
[Abstract]
[Full Text]
-
Stiles, B. G., Hale, M. L., Marvaud, J.-C., Popoff, M. R.
(2000). Clostridium perfringens Iota Toxin: Binding Studies and Characterization of Cell Surface Receptor by Fluorescence-Activated Cytometry. Infect. Immun.
68: 3475-3484
[Abstract]
[Full Text]
-
Barth, H., Blocker, D., Behlke, J., Bergsma-Schutter, W., Brisson, A., Benz, R., Aktories, K.
(2000). Cellular Uptake of Clostridium botulinum C2 Toxin Requires Oligomerization and Acidification. J. Biol. Chem.
275: 18704-18711
[Abstract]
[Full Text]
-
Barth, H., Pfeifer, G., Hofmann, F., Maier, E., Benz, R., Aktories, K.
(2001). Low pH-induced Formation of Ion Channels by Clostridium difficile Toxin B in Target Cells. J. Biol. Chem.
276: 10670-10676
[Abstract]
[Full Text]